344 Utilization of glucagon-like peptide-1 receptor agonist at the time of total hip arthroplasty for patients with morbid obesity

345 Dual Antiplatelet Therapy Does Not Increase Postoperative Bleeding Risk Following Elective Total Joint Arthroplasty

346 Is It Safe to Continue Clopidogrel During Primary Total Hip Arthroplasty?

347 Antidepressants Are Associated with Significantly Increased Risk of Postoperative Complications Following Total Hip Arthroplasty

348 Effect of GLP-1 Receptor Agonist Mediated Weight Loss on Outcomes After Total Hip Arthroplasty